Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I guess the sellers are waiting any longer.........
Sellers are patient - have to slap the ask unfortunately
Or maybe we just dry up the float and get rid of weak hands first.....
Don't take this the wrong way but apparently nobody gives a sh@t anymore and this has become dead money.
Those who still own it I guess want out, and nobody seems to want to buy it.
The glory days may be over..............
Seems to be stuck in the low 1 dollar range......................
Wow, looks good, some interesting files being filed. Higher prices coming IMHO.
January 14 8-K...a couple of observations.....
The OTC Markets profile page needs to get fully updated, and a more investor friendly/updated corporate website needs to be deployed. But assuming the company executes on its plans, and becomes active in the investor relations side of being a public company, there should be a number of opportunities for very nice IR-activity through much of this year.
The stock has managed to get to the $3 price area with minimal buying interest and minimal IR assistance. Should be somewhat interesting to see what might happen if the news flow begins/intensifies as the operational activity increases.
A couple of observations from the January 14 8-K......
1) Based on the information in that filing, it looks like the earliest the company began generating its first revenues was in April 2020. Gross margin was over 91%, which is quite interesting because included in that revenue was 300 of its nebulizers (medical devices to deliver the inhalant). I have no idea if that margin percentage is just an aberration or if it is indicative of what YBGJ might generate going forward on its product-related revenue. Margin percentages anywhere close to that would be excellent.
2) Kind of interesting to note that on September 11, 2020, shortly before Lina Liu purchased control of the MAGAA shell, an individual investor (Cheung Ho Shun) made a pretty large investment in Platinum International Biotech (he purchased 1.5% of the company). Post reverse merger, his $750K investment equals 1,755,000 shares of YBGJ with a cost basis a little under 43 cents per share.
Headquarters ceremony video news coverage.....
It’s mean they have injected their business, the price will achieve more $5??
February 6...headquarters ceremony, marketing strategy conference......
YBGJ held a ceremony yesterday for the transfer of its headquarters from Beijing to Chengdu. They also held a marketing strategy conference on the same day. A few snippets of interesting items from that ceremony and conference......
1) The groundbreaking ceremony marked the official transfer of the headquarters of Feibo International Group from Beijing to Chengdu, and also the official start of Feibo International's industrialization journey. Feibo International Group is a high-tech enterprise group focusing on the development and application of stem cell technology. Relying on the endometrial stem cell storage business, the group is committed to building the world's first endometrial stem cell public bank with scale advantages.
2) Chengdu Yubo (Yubo Global Biotechnology (Chengdu) Co., Ltd.) is a wholly-owned holding company of Yubo Biotechnology (Hong Kong) in China. It is the main company of Yubo Group's overseas listed companies in China and has strong assets. The total investment amounts to 50 million US dollars. Located in the global biomedical technology transformation center-Chengdu Medical City Third Medical Innovation Center, it has laboratories and cell storage warehouses, cell intelligent preparation platforms and medical device production lines that meet the latest standards.
3) With the support of the government and the park (Chengdu Medical City), Feibo International will also cooperate with universities and tertiary hospitals in the park to establish legal and compliant scientific research projects and carry out various special subjects for the clinical application of stem cells.
4) The chairman also specifically talked about the strategy of Viv-CELL Biotechnology Experience Center physical stores of Feibo International in 2021 and the specific requirements for opening stores and franchising. Ms. Liu Lina, Chief Financial Officer of Feibo International, explained to senior executives the upgrade of financial standards facing the rapid development of the group.
https://tinyurl.com/y2vfatev
it is interesting and fun to watch 'them' on buy days as they just hit all the asks up to a number
agreed that this has 'potential' for $10+
g/l!!
YBGJ($3.25)...adjusting my personal targets higher.....
wish all my stocks acted like this one; i keep wondering/waiting to see if they're going to 1) bring in volume? 2) rip it over $5?
g/l and Merry Christmas kt!
Nice action this morning! :)
kt
thanks for sharing about the English version!
Today’s open price looks so bad.??I found the company added English version website.
The asking volume is getting small,I think all of us are waiting its next actions in the further days.??
Things are looking great thus far; now for them to amp up the daily volume...
Additional info/pictures...listing ceremony.....
Last night and this morning Yubo has been updating/changing the corporate news section on its website. A more lengthy account of the December 8 conference/forum is now on its corporate website. It includes an additional 14 pictures from the event.
The morning forum session was primarily focused on general items related to the stem cell industry (applications, market prospects, etc). The afternoon session was heavily focused on items specific to Yubo/YBGJ -- its path to an American listing, current/future plans, etc.
Below is some translated text and a picture from the YBGJ-listing ceremony part of the afternoon session.....
http://www.yubogroup.com/details/info2-2.html
December 8 Beijing ceremony.....
Good choice for buying,the price will be over $4 soon??
YBGJ...encouraged by what I am seeing......
Yep....sometimes it's takes TD a couple of days to change these which can be frustrating!
looks like the symbol hasn't switched yet in TDA; not even sure i'll be able to watch the action
It’s very thin but will really come down to it’s volume increasing imo
This is an unwise seller, and I believe it will break $4 soon.
Excited for name/symbol change; unfortunately, looked like sellers showing up the last day or two
Magna-Lab Inc., MAGAA, changed to Yubo International Biotech Ltd., YBGJ:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
I visited the company's web site, and did some research and found that the company do stem cell industry, mainly for endometrial stem cells store and related application products chain store sales, China is actively developing the industry, according to the company changed its name, believe that will soon be into the business, I believe it would be a billions of dollars more than market value of company, stock prices in the short term will break the $4, believe me??
OTCX top bid all morning. That’s always been an indicator of upward move in my experience
thanks for the overview Potse, i'm hoping for $2+ as well and haven't sold any yet
it looks like there are some willing to sell here but hopefully we hold the $1 level
would like to see a pickup in volume at some point
g/l!
MAGAA($1.15)...still holding full position......
I'm still holding all of my MAGAA shares, and would like to see a solid break over that $2 price (or maybe the $3 level) before trying to trim any of my position.
My current average is under .45 per share, and I think there is a realistic possibility/potential of seeing a 10-bagger on at least some of those shares. It largely depends on just how tightly-held the legacy shares will be going forward over the next few weeks/months. And what the post-RM share structure will look like.
I see Yubo added an online order section (Yubo Mall) to its website sometime in late October or early November. After the company had removed the stock listing promotional video from its corporate website, I noticed a new listing promotional video appeared October 21 on a video website I monitor. This new video didn't have the english subtitles that the original video had, but it definitely was different and I remember it featured the profiles of another three people associated with the company. After seeing that video, I picked up an additional 8K shares at 40 cents in late October.
That video only stayed on this other website for a brief period of time before it was removed. But you still can find some Yubo-related promotional videos there that don't appear on the corporate website. Most of them are related to the stem cell nebulized inhalant and the cosmetics side of the company.......
http://v.qq.com/s/videoplus/733339481
http://yubogroup.com/
This is a rocket ship ready for takeoff. Watch!!
The price is rapid so fast
That would be very nice.....now I wish I had bought more lol. It's so thin!
hope this becomes one of those rare tickers that runs to billions marketcap ... seen it before with asian tickers
looking good so far
g/l!
Totally agree your opinion.
Yes...that would be nice. Very small float so it would take much.
kt
sure is; really hoping the volume picks up and we get over $2
MAGAA filed formal DEF 14C today. We shall see who Yubo International Biotech Limited is by Dec 2. My explain the slow move up the last few days.
Thanks. Not much info online...guess we wait and see.
Dear Magna-Lab, Inc. Stockholders:
The accompanying Information Statement (the “Information Statement”) is furnished by the Board of Directors (the “Board”) of Magna-Lab, Inc., a New York corporation (the “Company”), to holders of record as of the close of business on October 30, 2020 (the “Stockholders”) of the Company’s Class A and Class B common stock, $0.001 par value per share (the “Common Stock”), pursuant to Section 14(c) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The purpose of this Information Statement is to inform our Stockholders that, on October 22, 2020, the holder of a majority of the voting power of the outstanding capital stock of the Company acted by written consent in lieu of a special meeting of the Stockholders in accordance with Section 615 of the New York Business Corporation Consolidated Laws (“NYS”) to authorize and approve an amendment to the Company’s Articles of Incorporation changing the name of the Company to “Yubo International Biotech Limited” (the “Corporate Name Change”).
The Corporate Name Change will not become effective under SEC rules and regulations until at least 20 calendar days after the initial mailing of this Information Statement.
No action is required by you. The NYS permit holders of a majority of the voting power of a New York corporation to take stockholder action by written consent. Accordingly, the Company will not hold a meeting of its Stockholders to consider or vote upon the Corporate Name Change. This Information Statement is furnished solely for the purpose of informing our Stockholders of the action described herein before such action takes effect in accordance with Rule 14c-2 promulgated under the Exchange Act. This Information Statement is being distributed to the Stockholders on or about November 10, 2020. We encourage you to read this Information Statement carefully for further information regarding the corporate action described herein.
Please note that the Company’s controlling stockholder has voted to approve the Corporate Name Change. The number of votes held by the stockholder executing the written consent is sufficient to satisfy the stockholder vote requirement for such action under applicable law and the Company’s charter documents, so no additional votes will consequently be needed to approve the corporate action described herein.
WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.
By Order of the Board of Directors
/s/ Lina Liu
Lina Liu
Chief Financial Officer
Followers
|
14
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
319
|
Created
|
02/19/07
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |